Author: SRI International
-
Turning an aging Japan into a smarter Japan
Creative innovations based on the latest advanced tech could contribute valuable solutions to a wide range of associated challenges
-
75 Years of Innovation: augmented reality binoculars
The first mobile, precision, non-jitter, augmented reality binoculars
-
SRI spinout Wingsure develops AI-driven mobile insurance app for small farmers
Underserved farmers can now insure crops with rapid claim resolution through mobile phones using the Wingsure app
-
Cryogenic advances a must for quantum technology applications
Identifying the four priorities for cryogenic technologies that will expedite the transformation of QIST from a research-focused realm to commercial deployment
-
75 Years of Innovation: GPS-denied navigation
Several developments in robotic and vehicle navigation in GPS-denied scenarios
-
SRI International’s Parijat Bhatnagar receives DARPA award to continue groundbreaking research into engineered immunity
The prestigious award provides additional funds to continue developing cells that can be stimulated via extracorporeal devices to treat viral infections
-
SRI International enters drug discovery and research collaboration with Sanofi
Researchers will leverage SynFini, SRI’s artificial intelligence and automation platform, to accelerate development of small-molecule drug targets
-
SRI Education: Leading the Way in STEM & CS | July 2021
We’re at the forefront of integrated science, technology, engineering, and mathematics and computer science education.
-
Featured innovator: Claire Christensen
An educational media expert, Christensen specializes in early childhood media across a range of subjects including STEM, literacy and social-emotional learning.
-
Nomura-SRI Innovation Center will begin operations in July to accelerate adoption of emerging technologies among Japanese corporations
MENLO PARK, Calif., June 22, 2021: SRI International (SRI) and Nomura announced today that the Nomura-SRI Innovation Center (NSIC), located on SRI’s main campus in Menlo Park, Calif., will begin operations in July 2021. For industry leading businesses, keeping ahead of emerging technologies is vital to continued global success and growth. As NSIC members, Japanese enterprises…
-
Targeted Antigen Loaded Liposomes (TALL™)
SRI scientists exploit the human immune response to target cancer cells and extend the benefits of cancer immunotherapies. SRI’s Targeted Antigen Loaded Liposomes (TALL), a new immunotherapy with the potential to overcome these challenges and extend the benefits of immunotherapy to many more patients.
-
SRI leads collaborative effort that uncovered cybersecurity issues in industrial control system safety instrumentation and management
SRI worked with penetration testers and LOGIIC safety system experts to improve overall security of ICS safety systems